Synopsis: Neurimmune AG, a biopharmaceutical company, announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca’s…
Summary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
Summary : With the FDA’s emergency use authorization today of AstraZeneca’s long-acting antibody cocktail, the roughly 2% of U.S. residents who are…
Summary : The company also said studies are underway to provide information on the impact of the new Omicron variant on Evusheld,…
Abstract: The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (Dapagliflozin) within…